MedPath
TGA Approval

Idarubicin Injection 5 mg/5 mL (4) (406411)

406411

Idarubicin Injection 5 mg/5 mL (4)

Pfizer (Perth) Pty Ltd

March 20, 2023

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

idarubicin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Idarubicin Injection 5 mg/5 mL (4) (406411) - TGA 批准文号 | MedPath